International Biomedical AG

International Biomedical AG specializes in the Airborne TIS, a device intended for therapeutic interventions in respiratory care. Based on the description, it is likely designed for delivering aerosolized medication or supporting inhalation therapy, which are common treatments for respiratory conditions.

International Biomedical AG is headquartered in Switzerland, as indicated by the country designation (CH). This location places the company within the European regulatory framework for medical devices.

The Airborne TIS from International Biomedical AG is listed in the eudamed database, which is the official EU registry for medical devices under the EU Medical Device Regulation (MDR). This registry ensures transparency and traceability of devices marketed within the European Economic Area.

The Airborne TIS is classified as a Class IIb medical device under the EU Medical Device Regulation. This classification is based on factors like the device’s intended purpose, potential risks, and the level of intervention it involves. Class IIb devices require stricter regulatory controls than lower-risk classes but are not considered high-risk like Class III devices.